We are international
Donate
• health professionals TEXT SIZE   
Bringing the Experts to You



XIIth International Myeloma Workshop, Day 1, February 26th, 2009

  • 08:15-10:15 Multiple Myeloma - Molecular Pathways
  • 10:30-12:30 Multiple Myeloma - Signaling Pathways
  • 13:30-15:00 Myeloma Immune and Antibody Targets
  • 15:30-17:30 Continuum Of Treatment in Multiple Myeloma: A Chronic Disease (Sponsored by Celgene)
Complete Program Listing

2009 IMW Thursday Sessions

Multiple Myeloma - Molecular Pathways
Role of FISH in Myeloma Risk Stratification
XIIth International Myeloma Workshop in Washington, DC
Rafael Fonseca, M.D.
Mayo Clinic
Scottsdale, Arizona

Genetic Changes in Myeloma: Prognostic Implications
XIIth International Myeloma Workshop in Washington, DC
Herve Avet-Loiseau, M.D.
Institute de Biologie
Nantes, France

Redefining Risk Using Cytogenetics Changes
XIIth International Myeloma Workshop in Washington, DC
Johannes Drach, M.D.
University Hospital
Vienna, Austria

High Throughput Profiling in Myeloma Pathobiology and Prognosis
XIIth International Myeloma Workshop in Washington, DC
Gareth Morgan, M.D.
The Royal Marsden Hospital
Sutton, UK

New Insights In to the Molecular Basis of MM Pathogenesis & Prognosis
XIIth International Myeloma Workshop in Washington, DC
John Shaughnessy, PhD
University of Arkansas for Medical Science
Little Rock, Arkansas

Molecular Pathogenesis of MGUS and Multiple Myeloma
XIIth International Myeloma Workshop in Washington, DC
W. Michael Kuehl, M.D.
NCI Center for Cancer Research
Bethesda, MD
USA

Multiple Myeloma - Signaling Pathways
Inhibition of Signaling Cascades by Histone Deacetylase Inhibitors & AKT
XIIth International Myeloma Workshop in Washington, DC
Teru Hideshima, M.D.
Dana-Farber Cancer Institute
Boston, Massachusetts

Using Kinase Directed SiRNA Screen to Study Signaling Cascade in Development of Drug Resistance
XIIth International Myeloma Workshop in Washington, DC
Keith Stewart, M.D.
Mayo Clinic
Scottsdale, Arizona

Targeting NFkB Signaling in Myeloma
XIIth International Myeloma Workshop in Washington, DC
Lief Bergsagel, M.D.
Mayo Clinic,
Scottsdale, Arizona

Wnt/ß-catenin Signaling in Multiple Myeloma
XIIth International Myeloma Workshop in Washington, DC
John D. Shaughnessy Jr. PhD
University of Arkansas for Medical Science
Little Rock, Arkansas

Multiple Myeloma - Immune and Antibody Targets
Novel Antigenic Targets for Immunotherapy in Myeloma
XIIth International Myeloma Workshop in Washington, DC
Qing Yi,M.D.
MD Anderson Cancer Center
Houston, Texas

BAFF Signaling in Myeloma
XIIth International Myeloma Workshop in Washington, DC
Stephen Russell, M.D.

Antibody-based Therapies in Multiple Myeloma
Yu-Tzu Tai,M.D.
Dana-Farber Cancer Institute
Boston, Massachusetts

Continuum of Treatment in Multiple Myeloma: A Chronic Disease
Targeting the Right Patients to Achieve Overall Survival and Time to Progression Benefits
XIIth International Myeloma Workshop in Washington, DC
Sagar Lonial, M.D.
Emory Clinic
Atlanta, Georgia

Disease Control with active Long-Term Treatment
XIIth International Myeloma Workshop in Washington, DC
Antonio Palumbo, M.D.
Ospedale San Giovanni Battista
Torino, Italia

Cure Versus Control: Shifting the Treatment Paradigm in Newly Diagnosed Multiple Myeloma
XIIth International Myeloma Workshop in Washington, DC
Vincent Rajkumar,M.D.Rochester, Minnesota

Induction Therapy and Timing of ASCT
XIIth International Myeloma Workshop in Washington, DC
Michel Attal, M.D.
Hôpital Purpan
Toulouse, France

New Options for Elderly Patients with Newly Diagnosed Multiple Myeloma
XIIth International Myeloma Workshop in Washington, DC
Thierry Facon, M.D.
Hôpital C. Huriez, Lille, France

Case Presentation and Interactive Case Discussion
XIIth International Myeloma Workshop in Washington, DC
Vincent Rajkumar,M.D.Rochester, Minnesota

Immunomodulation: The Cornerstone of the Treatment of Multiple Myeloma
XIIth International Myeloma Workshop in Washington, DC
Nikhil Munshi, M.D.
Dana-Farber Cancer Institute
Boston, Massachusetts

Waldenströms Award Lecture
XIIth International Myeloma Workshop in Washington, DC
Dr. Brian G.M. Durie
Cedars Sinai Cancer Center
Los Angeles, California
USA